Viewing nowFamopan ODT 20 mg (Famotidine)
Famotidine 20mg
Orally disintegrating Tablet · Prescription medication
Korea Pharma Bio Co., Ltd.

MFDS item code 202202238 · Approved 2022.05.24 · Insurance code 659901730
Improvement of gastrointestinal diseases such as gastric ulcers, duodenal ulcers, and gastric mucosal lesions (erosions, bleeding)
This medication is used to treat peptic ulcers such as gastric ulcers, duodenal ulcers, and anastomotic ulcers. It is also effective for upper gastrointestinal bleeding (peptic ulcers, acute stress ulcers, hemorrhagic gastritis), gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It helps improve gastric mucosal erosions, bleeding, redness, and swelling during acute exacerbations of acute gastritis or chronic gastritis. In short, this drug restores mucosal damage caused by various gastrointestinal diseases and alleviates symptoms, improving the patient's health.
For famotidine, take 20 mg orally twice daily (after breakfast, after dinner or before bedtime). Additionally, 40 mg can be taken orally once daily (before bedtime). Adjust appropriately according to age and symptoms. For improvement of gastric mucosal lesions (erosions, bleeding, redness, swelling) in the following conditions: take 10 mg orally twice daily (after breakfast, after dinner or before bedtime), and additionally, 20 mg can be taken once daily.
This medicine contains the artificial sweetener aspartame. Aspartame is broken down into phenylalanine in the body, so patients with the genetic disorder phenylketonuria should not take this medicine. The daily intake of aspartame should be regulated to below 40 mg/kg as recommended by the World Health Organization; for a 60 kg adult, care should be taken to not exceed a maximum of 2.4 g per day. Patients with a history of allergic reactions to the components of this medicine or similar types of medications should not take this medicine. Patients with a history of allergies, impaired renal function, heart disease, decreased liver function, and the elderly should use this medicine with caution. In particular, patients with impaired renal function may have increased drug concentration, so the dosage should be reduced or the administration interval should be extended. During the use of this medicine, various serious side effects such as severe allergic reactions, hematologic abnormalities, skin diseases, liver dysfunction, muscle damage, cardiac rhythm abnormalities, consciousness disturbances, kidney inflammation, and pneumonia may occur, so symptoms should be monitored carefully. If unusual symptoms occur, stop taking the medicine immediately and consult with medical personnel. Furthermore, this medicine dissolves in the mouth but is not absorbed through the oral mucosa, so it must be swallowed with saliva or water. Patients undergoing dialysis should be cautious as the effectiveness of calcium supplements may decrease when this medication is used with phosphate binders. This medicine may interact with other drugs. In particular, when taken with certain antifungal agents or some anticancer drugs, the acid secretion inhibitory effect of this medicine may lower the blood concentration of those drugs, so it is crucial to inform medical personnel. The elderly are at risk of increased drug concentration due to decreased renal function, so dosage adjustments or changes in administration intervals may be necessary. Women who are pregnant or may become pregnant should only take this medicine when the benefits outweigh the risks, and breastfeeding women should discontinue nursing as this medicine may pass into breast milk. The safety of this medicine in children has not been fully confirmed, so caution is necessary for use. Finally, this medicine can conceal symptoms of gastric cancer, so it should only be used after confirming that the condition is not gastric cancer.
Shock, hypersensitivity (anaphylaxis, difficulty breathing, generalized flushing, angioedema, urticaria), pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia, Stevens-Johnson syndrome, Lyell syndrome, liver dysfunction, jaundice, rhabdomyolysis, QT prolongation, ventricular tachycardia, ventricular fibrillation, consciousness disturbances, seizures, interstitial nephritis, acute kidney failure, interstitial pneumonia, heart failure
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to prevent air and moisture ingress and should be kept at room temperature between 1 degree and 30 degrees. By storing it this way, the effectiveness of the medicine can be maintained for a long time.
White round orally disintegrating tablet
PTP - 10 tablets/box [10 tablets x PTP], PTP - 100 tablets/box [10 tablets x 10 PTP], Bottle - 100 tablets/bottle [100 tablets/bottle]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFamotidine 20mg
Orally disintegrating Tablet · Prescription medication
Korea Pharma Bio Co., Ltd.

Famotidine 20mg
Prescription medication
Dong-A ST Co., Ltd.

Famotidine 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Famotidine 20mg
Tablet · Prescription medication
(Stock Company) Ilhwa

Famotidine 20mg
Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Famotidine 20mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Famotidine 20mg
Prescription medication
(Stock Company) Seoul Pharmaceutical

Famotidine 20mg
Tablet · Prescription medication
(Stock Company) Genupharm
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.